Technical Analysis for MNKD - MannKind Corporation
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Resistance | Bearish | -1.02% | |
| NR7 | Range Contraction | -0.73% | |
| NR7-2 | Range Contraction | -0.73% | |
| Stochastic Reached Oversold | Weakness | -0.73% | |
| Oversold Stochastic | Weakness | -0.73% | |
| Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 1.34% | |
| NR7 | Range Contraction | 1.34% | |
| Inside Day | Range Contraction | 1.34% | |
| Gapped Up | Strength | 1.34% | |
| Fell Below 20 DMA | Bearish | 0.15% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakdown | about 1 hour ago |
| Down 2 % | about 1 hour ago |
| Fell Below Previous Day's Low | about 1 hour ago |
| Down 1% | about 1 hour ago |
| 2x Volume Pace | about 2 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/05/2024
MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States. Its lead product candidate includes AFREZZA inhalation powder, an insulin that is in late-stage clinical investigation for the treatment of adults with type 1 or type 2 diabetes for the control of hyperglycemia. The company also develops MedTone and Dreamboat inhaler devices. MannKind Corporation was founded in 1991 and is headquartered in Valencia, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Cancer Organ Systems Boat Diabetes Therapeutic Products Endocrine System Insulin Hyperglycemia Inhaler
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Cancer Organ Systems Boat Diabetes Therapeutic Products Endocrine System Insulin Hyperglycemia Inhaler
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 7.63 |
| 52 Week Low | 3.17 |
| Average Volume | 2,288,897 |
| 200-Day Moving Average | 5.28 |
| 50-Day Moving Average | 6.68 |
| 20-Day Moving Average | 7.00 |
| 10-Day Moving Average | 7.03 |
| Average True Range | 0.30 |
| RSI (14) | 50.25 |
| ADX | 20.2 |
| +DI | 22.55 |
| -DI | 24.49 |
| Chandelier Exit (Long, 3 ATRs) | 6.73 |
| Chandelier Exit (Short, 3 ATRs) | 7.20 |
| Upper Bollinger Bands | 7.52 |
| Lower Bollinger Band | 6.48 |
| Percent B (%b) | 0.39 |
| BandWidth | 14.89 |
| MACD Line | 0.08 |
| MACD Signal Line | 0.14 |
| MACD Histogram | -0.067 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 7.24 | ||||
| Resistance 3 (R3) | 7.25 | 7.15 | 7.18 | ||
| Resistance 2 (R2) | 7.15 | 7.05 | 7.14 | 7.16 | |
| Resistance 1 (R1) | 7.01 | 7.00 | 7.00 | 7.00 | 7.14 |
| Pivot Point | 6.91 | 6.91 | 6.90 | 6.90 | 6.91 |
| Support 1 (S1) | 6.77 | 6.81 | 6.76 | 6.76 | 6.62 |
| Support 2 (S2) | 6.67 | 6.76 | 6.66 | 6.60 | |
| Support 3 (S3) | 6.53 | 6.67 | 6.58 | ||
| Support 4 (S4) | 6.52 |
